1 October 2023 - The October 2023 issue of the New Zealand Pharmaceutical Schedule is now available and in effect.

There are a few new/revised listings of note this month.

• Emicizumab (Hemlibra) - new indication
• Ocrelizumab (Ocrevus) - new indication

Read New Zealand Pharmaceutical Schedule update